Entries by Greg Gilman

Psychedelic Business Spotlight – February 4

Levitee Labs Announces Interim CEO and Board of Directors Shuffle This week in psychedelic business news, Levitee Labs Inc. (CSE: LVT) (OTC: LVTTF) (FSE: 7H7), a psychedelic medicine and wellness company, has appointed Philip van den Berg as Chief Executive Officer and to the Board of Directors, replacing Pouya Farmand, who will be moving to […]